00009399302023Q1false--03-31P12MP18M00009399302022-04-012022-06-3000009399302022-07-31xbrli:sharesiso4217:USD00009399302021-04-012021-06-30iso4217:USDxbrli:shares00009399302022-06-3000009399302021-06-3000009399302022-03-310000939930us-gaap:CommonStockMember2022-03-310000939930us-gaap:RetainedEarningsMember2022-03-310000939930us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000939930us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-03-310000939930us-gaap:NoncontrollingInterestMember2022-03-310000939930us-gaap:RetainedEarningsMember2022-04-012022-06-300000939930us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000939930us-gaap:AccumulatedTranslationAdjustmentMember2022-04-012022-06-300000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-012022-06-300000939930us-gaap:CommonStockMember2022-06-300000939930us-gaap:RetainedEarningsMember2022-06-300000939930us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000939930us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000939930us-gaap:NoncontrollingInterestMember2022-06-300000939930us-gaap:CommonStockMember2021-03-310000939930us-gaap:RetainedEarningsMember2021-03-310000939930us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000939930us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-03-310000939930us-gaap:NoncontrollingInterestMember2021-03-3100009399302021-03-310000939930us-gaap:RetainedEarningsMember2021-04-012021-06-300000939930us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000939930us-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-012021-06-300000939930us-gaap:CommonStockMember2021-06-300000939930us-gaap:RetainedEarningsMember2021-06-300000939930us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000939930us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000939930us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-06-300000939930us-gaap:NoncontrollingInterestMember2021-06-3000009399302022-01-012022-03-31pyx:segment0000939930pyx:LeafTobaccoOtherRegionsSegmentMember2022-01-012022-03-310000939930pyx:ProductOtherThanLeafMember2022-01-012022-03-310000939930pyx:LeafTobaccoNorthAmericaSegmentMemberus-gaap:ProductMember2022-04-012022-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMemberus-gaap:ProductMember2021-04-012021-06-300000939930us-gaap:ServiceMemberpyx:LeafTobaccoNorthAmericaSegmentMember2022-04-012022-06-300000939930us-gaap:ServiceMemberpyx:LeafTobaccoNorthAmericaSegmentMember2021-04-012021-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMember2022-04-012022-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMember2021-04-012021-06-300000939930pyx:OtherProductsAndServicesSegmentMember2022-04-012022-06-300000939930pyx:OtherProductsAndServicesSegmentMember2021-04-012021-06-30xbrli:pure0000939930us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberpyx:FIGRNorfolkMember2022-01-282022-01-28iso4217:CAD0000939930us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberpyx:FIGREastAndIntangibleAssetsOfFIGRBrandsMember2021-01-282021-01-280000939930pyx:DebtorInPossessionFinancingFacilityMemberpyx:CanadianDebtorInPossessionFacilityMember2022-06-300000939930pyx:AdamsInternationalLtdMember2022-06-300000939930pyx:AllianceOneIndustriesIndiaPrivateLtdMember2022-06-300000939930pyx:ChinaBrasilTobacosExportadoraSAMember2022-06-300000939930pyx:OryantalTutunPaketlemeMember2022-06-300000939930pyx:PurilumLLCMember2022-06-300000939930pyx:SiamTobaccoExportCompanyMember2022-06-300000939930us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-04-012022-06-300000939930us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-04-012021-06-300000939930us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-06-300000939930us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2021-06-300000939930us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember2022-03-310000939930us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-06-300000939930us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-06-300000939930us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-03-310000939930us-gaap:CustomerRelationshipsMember2022-04-012022-06-300000939930us-gaap:CustomerRelationshipsMember2022-03-310000939930us-gaap:CustomerRelationshipsMember2022-06-300000939930us-gaap:TechnologyBasedIntangibleAssetsMember2022-04-012022-06-300000939930us-gaap:TechnologyBasedIntangibleAssetsMember2022-03-310000939930us-gaap:TechnologyBasedIntangibleAssetsMember2022-06-300000939930us-gaap:TradeNamesMember2022-04-012022-06-300000939930us-gaap:TradeNamesMember2022-03-310000939930us-gaap:TradeNamesMember2022-06-300000939930us-gaap:CustomerRelationshipsMember2021-04-012022-03-310000939930us-gaap:CustomerRelationshipsMember2021-03-310000939930us-gaap:TechnologyBasedIntangibleAssetsMember2021-04-012022-03-310000939930us-gaap:TechnologyBasedIntangibleAssetsMember2021-03-310000939930us-gaap:TradeNamesMember2021-04-012022-03-310000939930us-gaap:TradeNamesMember2021-03-3100009399302021-04-012022-03-310000939930pyx:ABLFacilityMemberus-gaap:LineOfCreditMember2022-06-300000939930pyx:ABLFacilityMemberus-gaap:LineOfCreditMember2021-06-300000939930pyx:ABLFacilityMemberus-gaap:LineOfCreditMember2022-03-310000939930pyx:ExitABLCreditFacilityMemberus-gaap:LineOfCreditMember2022-06-300000939930pyx:ExitABLCreditFacilityMemberus-gaap:LineOfCreditMember2021-06-300000939930pyx:ExitABLCreditFacilityMemberus-gaap:LineOfCreditMember2022-03-310000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2022-06-300000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2021-06-300000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2022-03-310000939930pyx:SeniorSecuredFirstLienNotesDue2024Memberus-gaap:SeniorNotesMember2022-06-300000939930pyx:SeniorSecuredFirstLienNotesDue2024Memberus-gaap:SeniorNotesMember2021-06-300000939930pyx:SeniorSecuredFirstLienNotesDue2024Memberus-gaap:SeniorNotesMember2022-03-310000939930pyx:TermLoansMember2022-06-300000939930pyx:TermLoansMember2021-06-300000939930pyx:TermLoansMember2022-03-310000939930pyx:OtherLongTermDebtMember2022-06-300000939930pyx:OtherLongTermDebtMember2021-06-300000939930pyx:OtherLongTermDebtMember2022-03-310000939930us-gaap:NotesPayableToBanksMember2022-06-300000939930us-gaap:NotesPayableToBanksMember2021-06-300000939930us-gaap:NotesPayableToBanksMember2022-03-310000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2022-04-012022-06-300000939930pyx:SeniorSecuredFirstLienNotesDue2024Memberus-gaap:SeniorNotesMember2022-04-012022-06-300000939930pyx:TermLoanCreditFacilityMember2022-06-300000939930pyx:PNCABLCreditFacilityMemberus-gaap:LineOfCreditMember2022-02-080000939930pyx:RevolvingLineOfCreditMemberpyx:PNCABLCreditFacilityMember2022-02-080000939930pyx:ABLCreditFacilityMemberus-gaap:LineOfCreditMember2020-08-240000939930pyx:PNCABLCreditFacilityMemberus-gaap:LineOfCreditMember2022-02-082022-02-080000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2021-04-230000939930pyx:AllianceOneInternationalTabakBVMemberpyx:AllianceOneBrazilMember2021-04-230000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMember2022-06-020000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-06-022022-06-020000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMembersrt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-06-020000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMemberus-gaap:BaseRateMember2022-06-022022-06-020000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMember2022-06-022022-06-020000939930us-gaap:EquityMethodInvesteeMemberpyx:GlendonCapitalManagementLPMember2020-09-030000939930us-gaap:EquityMethodInvesteeMemberpyx:MonarchAlternativeCapitalLPMember2020-09-030000939930us-gaap:EquityMethodInvesteeMemberpyx:OwlCreekAssetManagementLPMember2022-02-100000939930us-gaap:EquityMethodInvesteeMemberpyx:OwlCreekAssetManagementLPMember2021-12-310000939930pyx:SeniorSecuredFirstLienNotesDue2024Memberus-gaap:SeniorNotesMember2020-08-240000939930pyx:TermLoanCreditAgreementMemberpyx:TermLoanCreditFacilityMember2020-08-240000939930srt:MinimumMemberus-gaap:LineOfCreditMember2022-04-012022-06-300000939930srt:MaximumMemberus-gaap:LineOfCreditMember2022-04-012022-06-300000939930pyx:ForeignSeasonalLinesOfCreditWithEasternAndSouthernAfricanTradeAndDevelopmentBankMemberus-gaap:ForeignLineOfCreditMembercountry:MW2022-06-300000939930pyx:ForeignSeasonalLinesOfCreditWithEasternAndSouthernAfricanTradeAndDevelopmentBankMembercountry:TZus-gaap:ForeignLineOfCreditMember2022-06-300000939930pyx:ForeignSeasonalLinesOfCreditWithEasternAndSouthernAfricanTradeAndDevelopmentBankMembercountry:ZMus-gaap:ForeignLineOfCreditMember2022-06-300000939930us-gaap:LondonInterbankOfferedRateLIBORMemberpyx:ForeignSeasonalLinesOfCreditWithEasternAndSouthernAfricanTradeAndDevelopmentBankMemberus-gaap:ForeignLineOfCreditMember2022-06-012022-06-010000939930us-gaap:LondonInterbankOfferedRateLIBORMemberpyx:ForeignSeasonalLinesOfCreditWithEasternAndSouthernAfricanTradeAndDevelopmentBankMemberus-gaap:ForeignLineOfCreditMember2022-06-302022-06-300000939930pyx:TDBFacilityMemberus-gaap:LineOfCreditMember2022-06-30pyx:program0000939930pyx:AccountsReceivableSecuritizationProgramOneMember2022-06-300000939930pyx:AccountsReceivableSecuritizationProgramTwoMember2022-06-300000939930us-gaap:CostOfSalesMember2022-04-012022-06-300000939930us-gaap:CostOfSalesMember2021-04-012021-06-300000939930us-gaap:FairValueInputsLevel2Member2022-06-300000939930us-gaap:FairValueInputsLevel3Member2022-06-300000939930us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000939930us-gaap:FairValueInputsLevel2Member2021-06-300000939930us-gaap:FairValueInputsLevel3Member2021-06-300000939930us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-06-300000939930us-gaap:FairValueInputsLevel2Member2022-03-310000939930us-gaap:FairValueInputsLevel3Member2022-03-310000939930us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-03-310000939930pyx:SecuritizedBeneficialInterestsMember2022-03-310000939930us-gaap:LongTermDebtMember2022-03-310000939930us-gaap:GuaranteesMember2022-03-310000939930pyx:SecuritizedBeneficialInterestsMember2021-03-310000939930us-gaap:LongTermDebtMember2021-03-310000939930us-gaap:GuaranteesMember2021-03-310000939930pyx:SecuritizedBeneficialInterestsMember2022-04-012022-06-300000939930us-gaap:GuaranteesMember2022-04-012022-06-300000939930pyx:SecuritizedBeneficialInterestsMember2021-04-012021-06-300000939930us-gaap:GuaranteesMember2021-04-012021-06-300000939930us-gaap:LongTermDebtMember2022-04-012022-06-300000939930us-gaap:LongTermDebtMember2021-04-012021-06-300000939930pyx:SecuritizedBeneficialInterestsMember2022-06-300000939930us-gaap:LongTermDebtMember2022-06-300000939930us-gaap:GuaranteesMember2022-06-300000939930pyx:SecuritizedBeneficialInterestsMember2021-06-300000939930us-gaap:LongTermDebtMember2021-06-300000939930us-gaap:GuaranteesMember2021-06-300000939930srt:MinimumMemberus-gaap:PensionPlansDefinedBenefitMember2021-11-192021-11-190000939930srt:MaximumMemberus-gaap:PensionPlansDefinedBenefitMember2021-11-192021-11-190000939930us-gaap:PensionPlansDefinedBenefitMember2022-06-300000939930pyx:SuitNumberThreeMemberpyx:TaxAssessmentMember2007-10-260000939930pyx:SuitNumberThreeMemberpyx:TaxAssessmentMember2022-06-300000939930pyx:SuitNumberSixMemberpyx:TaxAssessmentMember2014-03-180000939930pyx:SuitNumberSixMemberpyx:TaxAssessmentMember2022-06-300000939930pyx:SuitNumberFourMemberpyx:TaxAssessmentMember2022-06-30pyx:facility0000939930pyx:OtherReceivablesMember2022-06-300000939930pyx:OtherReceivablesMember2021-06-300000939930pyx:OtherReceivablesMember2022-03-310000939930us-gaap:AccountsPayableMember2022-06-300000939930us-gaap:AccountsPayableMember2021-06-300000939930us-gaap:AccountsPayableMember2022-03-310000939930pyx:ContractWithCustomerLiabilityCurrentMember2022-06-300000939930pyx:ContractWithCustomerLiabilityCurrentMember2021-06-300000939930pyx:ContractWithCustomerLiabilityCurrentMember2022-03-310000939930pyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:LineOfCreditMember2021-12-302021-12-300000939930us-gaap:EquityMethodInvesteeMember2022-06-300000939930us-gaap:EquityMethodInvesteeMember2021-06-300000939930us-gaap:EquityMethodInvesteeMember2022-03-310000939930pyx:DebtorInPossessionFinancingFacilityMemberpyx:CanadianDebtorInPossessionFacilityMember2021-06-300000939930pyx:DebtorInPossessionFinancingFacilityMemberpyx:CanadianDebtorInPossessionFacilityMember2022-03-310000939930pyx:LeafTobaccoNorthAmericaSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000939930pyx:OtherProductsAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300000939930pyx:OtherProductsAndServicesSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300000939930us-gaap:OperatingSegmentsMember2022-04-012022-06-300000939930us-gaap:OperatingSegmentsMember2021-04-012021-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMember2022-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMember2021-06-300000939930pyx:LeafTobaccoNorthAmericaSegmentMember2022-03-310000939930pyx:OtherProductsAndServicesSegmentMember2022-06-300000939930pyx:OtherProductsAndServicesSegmentMember2021-06-300000939930pyx:OtherProductsAndServicesSegmentMember2022-03-310000939930pyx:IntabexMemberpyx:DelayedDrawTermLoanFacilityCreditAgreementMemberus-gaap:SubsequentEventMemberus-gaap:LineOfCreditMember2022-07-280000939930pyx:TermLoanCreditAgreementMemberpyx:IntabexMemberus-gaap:SubsequentEventMemberus-gaap:LineOfCreditMember2022-07-280000939930pyx:TermLoanCreditAgreementMemberpyx:IntabexMemberus-gaap:SubsequentEventMemberus-gaap:LineOfCreditMember2022-07-282022-07-280000939930pyx:TermLoanCreditAgreementMemberpyx:IntabexMemberus-gaap:SubsequentEventMemberus-gaap:LineOfCreditMember2022-07-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2022.

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _______ TO _______.
000-25734
(Commission File Number)
pyx-20220630_g1.jpg
Pyxus International, Inc.
(Exact name of registrant as specified in its charter)

Virginia 85-2386250
(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
 8001 Aerial Center Parkway
Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)
(919) 379-4300
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.   

Large accelerated filer                                           
Non-accelerated filer   
Accelerated filer   ☐                    

Smaller reporting company    
Emerging growth company    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transaction period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes No

Indicate by check mark if the registrant has filed all documents and reports required to be filed under Sections 12, 13, or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.  Yes No

As of July 31, 2022, the registrant had 24,999,947 shares outstanding of Common Stock (no par value).
-1-




-2-


Part I. Financial Information

Item 1. Financial Statements

Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
(in thousands, except per share data) Three months ended June 30, 2022 Three months ended June 30, 2021
Sales and other operating revenues $ 343,905  $ 333,290 
Cost of goods and services sold 303,150  291,170 
Gross profit 40,755  42,120 
Selling, general, and administrative expenses 34,588  33,845 
Other income, net 1,085  162 
Restructuring and asset impairment charges 300  233 
Operating income 6,952  8,204 
Loss on deconsolidation/disposition of subsidiaries 599  — 
Interest expense, net 25,474  26,840 
Loss before income taxes and other items (19,121) (18,636)
Income tax benefit 867  8,439 
Income (loss) from unconsolidated affiliates 3,749  (1,431)
Net loss (14,505) (11,628)
Net income (loss) attributable to noncontrolling interests 158  (120)
Net loss attributable to Pyxus International, Inc. $ (14,663) $ (11,508)
Loss per share:
Basic and diluted $ (0.59) $ (0.46)
Weighted average number of shares outstanding:
Basic and diluted 25,000  25,000 
See "Notes to Condensed Consolidated Financial Statements"










-3-


Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Loss
(Unaudited)
(in thousands) Three months ended June 30, 2022 Three months ended June 30, 2021
Net loss $ (14,505) $ (11,628)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment 947  689 
Cash flow hedges (1,503) 4,328 
Total other comprehensive (loss) income, net of tax (556) 5,017 
Total comprehensive loss (15,061) (6,611)
Comprehensive income (loss) attributable to noncontrolling interests 158  (120)
Comprehensive loss attributable to Pyxus International, Inc. $ (15,219) $ (6,491)
See "Notes to Condensed Consolidated Financial Statements"



-4-


Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Unaudited)
(in thousands) June 30, 2022 June 30, 2021 March 31, 2022
Assets
Current assets
Cash and cash equivalents $ 165,441  $ 79,593  $ 198,777 
Restricted cash 9,495  2,538  2,148 
Trade receivables, net 155,976  198,241  247,677 
Other receivables 26,859  33,711  12,511 
Inventories, net 980,070  854,042  749,427 
Advances to tobacco suppliers, net 44,070  36,706  48,932 
Recoverable income taxes 8,747  10,894  7,906 
Prepaid expenses 44,513  35,217  34,817 
Other current assets 16,672  19,713  25,452 
Total current assets 1,451,843  1,270,655  1,327,647 
Restricted cash —  389  389 
Investments in unconsolidated affiliates 87,139  85,651  95,420 
Goodwill —  36,853  — 
Other intangible assets, net 42,052  49,935  45,061 
Deferred income taxes, net 8,871  10,179  6,498 
Long-term recoverable income taxes 4,571  4,167  4,588 
Other noncurrent assets 46,456  42,127  45,424 
Right-of-use assets 35,636  41,540  35,979 
Property, plant, and equipment, net 135,878  140,332  137,521 
Total assets $ 1,812,446  $ 1,681,828  $ 1,698,527 
Liabilities and Stockholders’ Equity
Current liabilities
Notes payable to banks $ 545,224  $ 403,792  $ 378,612 
Accounts payable 144,915  88,807  179,012 
Advances from customers 46,071  29,631  52,998 
Accrued expenses and other current liabilities 91,054  91,426  82,239 
Income taxes payable 6,729  4,110  5,592 
Operating leases payable 8,535  8,961  8,065 
Current portion of long-term debt 13,781  2,686  107,856 
Total current liabilities 856,309  629,413  814,374 
Long-term taxes payable 5,783  6,703  6,703 
Long-term debt 678,777  669,793  580,477 
Deferred income taxes 9,925  14,254  11,670 
Liability for unrecognized tax benefits 12,173  15,883  14,401 
Long-term leases 26,473  31,843  28,604 
Pension, postretirement, and other long-term liabilities 59,748  66,610  60,927 
Total liabilities 1,649,188  1,434,499  1,517,156 
Commitments and contingencies
Stockholders’ equity
Common Stock—no par value:
Authorized shares (250,000 for all periods)
Issued shares (25,000 for all periods)
390,290  391,089  390,290 
Retained deficit (233,476) (148,202) (218,813)
Accumulated other comprehensive income (loss) 3,248  (1,716) 3,804 
Total stockholders’ equity of Pyxus International, Inc. 160,062  241,171  175,281 
Noncontrolling interests 3,196  6,158  6,090 
Total stockholders’ equity 163,258  247,329  181,371 
Total liabilities and stockholders’ equity $ 1,812,446  $ 1,681,828  $ 1,698,527 
See "Notes to Condensed Consolidated Financial Statements"



-5-



Pyxus International, Inc. and Subsidiaries
Condensed Statements of Consolidated Stockholders' Equity
(Unaudited)
Accumulated Other Comprehensive Income (Loss)
(in thousands) Common
Stock
Retained
Deficit
Currency Translation Adjustment Pensions,
Net of Tax
Derivatives, Net of Tax Noncontrolling
Interests
Total Stockholders' Equity
Balance, March 31, 2022 $ 390,290  $ (218,813) $ (8,873) $ 6,328  $ 6,349  $ 6,090  $ 181,371 
Net loss attributable to Pyxus International, Inc. —  (14,663) —  —  —  158  (14,505)
Other —  —  —  —  —  (3,052) (3,052)
Other comprehensive loss, net of tax —  —  947  —  (1,503) —  (556)
Balance, June 30, 2022 $ 390,290  $ (233,476) $ (7,926) $ 6,328  $ 4,846  $ 3,196  $ 163,258 

Balance, March 31, 2021 $ 391,089  $ (136,686) $ (4,649) $ 541  $ (2,625) $ 6,270  $ 253,940 
Net loss attributable to Pyxus International, Inc. —  (11,508) —  —  —  (120) (11,628)
Other —  (8) —  —  —  — 
Other comprehensive income, net of tax —  —  689  —  4,328  —  5,017 
Balance, June 30, 2021 $ 391,089  $ (148,202) $ (3,960) $ 541  $ 1,703  $ 6,158  $ 247,329 

See "Notes to Condensed Consolidated Financial Statements"
-6-


Pyxus International, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(in thousands) Three months ended June 30, 2022 Three months ended June 30, 2021
Operating Activities:
Net loss $ (14,505) $ (11,628)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization 5,929  4,066 
Loss on deconsolidation/disposition of subsidiaries 599  — 
Debt amortization/interest 5,530  6,132 
Loss on foreign currency transactions 39  1,325 
Income from unconsolidated affiliates, net of dividends 7,773  10,567 
Changes in operating assets and liabilities, net
Trade and other receivables 26,612  (59,058)
Inventories and advances to tobacco suppliers (228,994) (118,268)
Deferred items (8,214) (3,643)
Recoverable income taxes (796) (5,971)
Payables and accrued expenses (25,249) (17,950)
Advances from customers (6,997) 17,515 
Prepaid expenses (6,027) (367)
Income taxes 1,313  (4,320)
Other operating assets and liabilities 3,396  118 
Other, net (2,899) (4,475)
Net cash used by operating activities (242,490) (185,957)
Investing Activities:
Purchases of property, plant, and equipment (2,210) (3,815)
Collections on beneficial interests on securitized trade receivables 45,468  37,681 
DIP loan to deconsolidated subsidiary —  (5,229)
Proceeds from settlement of debt claims from deconsolidated subsidiaries 2,011  — 
Other, net 1,766  1,017 
Net cash provided by investing activities 47,035  29,654 
Financing Activities:
Net proceeds and repayments from short-term borrowings 170,419  29,015 
Proceeds from DDTL facility —  117,600 
Debt issuance costs (2,036) (6,148)
Other, net 372  129 
Net cash provided by financing activities 168,755  140,596 
Effect of exchange rate changes on cash 322  514 
Decrease in cash, cash equivalents, and restricted cash (26,378) (15,193)
Cash and cash equivalents at beginning of period 198,777  92,705 
Restricted cash at beginning of period 2,537  5,008 
Cash, cash equivalents, and restricted cash at end of period $ 174,936  $ 82,520 
Other information:
Cash paid for income taxes, net $ 5,027  $ 4,871 
Cash paid for interest, net 12,704  15,856 
Noncash investing activities:
Noncash amounts obtained as a beneficial interest in exchange for transferring trade receivables in a securitization transaction 29,033  38,498 
See "Notes to Condensed Consolidated Financial Statements"
-7-



Pyxus International, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(in thousands, except per share data)
8
9
9
9

1. Basis of Presentation and Summary of Significant Accounting Policies
The accompanying condensed consolidated financial statements represent the consolidation of Pyxus International, Inc. (the "Company", "Pyxus", "we", or "us") and all companies that Pyxus directly or indirectly controls, either through majority ownership or otherwise. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, the normal and recurring adjustments necessary for fair statement of financial position, results of operations, and cash flows at the dates and for the periods presented have been included. Intercompany accounts and transactions have been eliminated.
These condensed consolidated interim financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the fiscal year ended March 31, 2022 filed on June 14, 2022. Due to the seasonal nature of the Company’s business, the results of operations for a fiscal quarter are not necessarily indicative of the operating results that may be attained for other quarters or a full fiscal year.
Segment Information
During the year ended March 31, 2022, the Company reevaluated its operating and reportable segments under Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 280 - Segment Reporting. As a result of this reevaluation, effective as of the fourth quarter of the fiscal year ended March 31, 2022, the Company has eight operating segments organized by geographic area and product category and are aggregated into one reportable segment for financial reporting purposes: Leaf. Based on our reevaluation, the Company concluded that the economic characteristics of our five Leaf region operations in North America, South America, Europe, Asia, and Africa were similar. Each geographic region derives its revenues mainly from shipping processed tobacco to manufacturers of cigarettes and other consumer tobacco products around the world, with a smaller percentage of revenue in each region being derived from performing third-party tobacco processing services. The three product category operating segments other than Leaf do not individually or in the aggregate meet the quantitative and qualitative thresholds to be individually reportable and have been combined and reported in the "All Other" category for purposes of reconciliation of respective balances for the Leaf segment to the condensed consolidated financial statements. Prior-period segment financial information has been revised to conform to the current-year presentation. See "Note 19. Segment Information" for additional information.
-8-


2. New Accounting Standards
Recently Adopted Accounting Pronouncements
In November 2021, the FASB issued Accounting Standards Update ("ASU") No. 2021-10, Disclosures by Business Entities about Government Assistance. This ASU created ASC Topic 832, Government Assistance, and requires certain information be disclosed regarding assistance received from a government entity when either a grant or contribution accounting model is applied. The new disclosures are required for annual periods for transactions with a government entity that are within the scope of the Topic. The new disclosure guidance was adopted prospectively and became effective for the Company on April 1, 2022. The adoption of this new accounting standard is not expected to have a material impact on the Company's annual disclosures for fiscal year 2023.

3. Revenue Recognition
Product revenue is primarily processed tobacco sold to the customer. Processing and other revenues are mainly contracts to process customer-owned green tobacco. During processing, ownership remains with the customers. All Other revenue is primarily composed of revenue from the sale of e-liquids and non-tobacco agriculture product revenue. The following disaggregates sales and other operating revenues by major source, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:

Three months ended June 30, 2022 Three months ended June 30, 2021
Leaf:
Product revenue $ 322,884  $ 311,741 
Processing and other revenues 17,742  18,117 
Total sales and other operating revenues 340,626  329,858 
All Other:
Total sales and other operating revenues 3,279  3,432 
Total sales and other operating revenues $ 343,905  $ 333,290 

The following summarizes activity in the allowance for expected credit losses:

Three months ended June 30, 2022 Three months ended June 30, 2021
Balance, beginning of period $ (24,541) $ (20,900)
Additions (165) (380)
Write-offs 1,376  147 
Balance, end of period (23,330) (21,133)
Trade receivables 179,306  219,374 
Trade receivables, net $ 155,976  $ 198,241 

4. Income Taxes
The Company's quarterly provision for income taxes has generally been calculated using the annual effective tax rate method ("AETR method"), which applies an estimated annual effective tax rate to pre-tax income or loss. The AETR method was used to calculate the provision for income taxes for the prior fiscal years, for which the Company reported income tax benefits in each prior reporting period. As of June 30, 2022, the AETR method produced an unreliable estimate of the Company’s annual effective tax rate; therefore, the Company recorded its interim income tax provision using the discrete method, as allowed under ASC 740-270, Income Taxes - Interim Reporting. Using the discrete method, the Company determined current and deferred income tax expense as if the three-month interim period of the current fiscal year were an annual period.

The effective tax rate for the three months ended June 30, 2022 and 2021 was 4.5% and 45.3%, respectively. For the three months ended June 30, 2022 and 2021, the difference between the Company’s effective rate and the U.S. statutory rate of 21% is primarily due to the impact of net foreign exchange effects, non-deductible interest, and variations in the expected jurisdictional mix of earnings.

-9-


5. Loss Per Share
The following summarizes the computation of loss per share:

Three months ended June 30, 2022 Three months ended June 30, 2021
Basic and diluted loss per share:
Net loss attributable to Pyxus International, Inc. $ (14,663) $ (11,508)
Shares:
Weighted average number of shares outstanding 25,000  25,000 
Basic and diluted loss per share $ (0.59) $ (0.46)

6. Inventories, Net
The following summarizes the composition of inventories, net:

June 30, 2022 June 30, 2021 March 31, 2022
Processed tobacco $ 646,539  $ 584,791  $ 517,613 
Unprocessed tobacco 290,913  232,893  193,406 
Other tobacco related 33,739  25,471  29,694 
All Other
8,879  10,887  8,714 
Total $ 980,070  $ 854,042  $ 749,427 

-10-


7. CCAA Proceeding and Deconsolidation of Subsidiaries
On January 21, 2021, Figr Norfolk Inc. ("Figr Norfolk"), Figr Brands, Inc. ("Figr Brands"), and Canada’s Island Garden Inc. ("Figr East," and together with Figr Norfolk and Figr Brands, the "Canadian Cannabis Subsidiaries"), which, prior to their sale, were indirect subsidiaries of the Company, applied for relief from their respective creditors pursuant to Canada’s Companies’ Creditors Arrangement Act (the "CCAA") in the Ontario Superior Court of Justice (Commercial List) (the "Canadian Court") in Ontario, Canada as Court File No. CV-21-00655373-00CL (the "CCAA Proceeding"). On January 21, 2021 (the "Order Date"), upon application by the Canadian Cannabis Subsidiaries, the Canadian Court issued an order for creditor protection of the Canadian Cannabis Subsidiaries pursuant to the provisions of the CCAA and the appointment of FTI Consulting Canada Inc. to serve as the Canadian Court-appointed monitor of the Canadian Cannabis Subsidiaries during the pendency of the CCAA Proceeding (the "Monitor"). The administration of the CCAA Proceeding, including the Canadian Court's appointment of the Monitor and the related authority of the Monitor, including approval rights with respect to significant actions of the Canadian Cannabis Subsidiaries during the pendency of the CCAA Proceeding, resulted in the Company losing control (in accordance with U.S. GAAP) of the Canadian Cannabis Subsidiaries at that time, and the deconsolidation on January 20, 2021 of the Canadian cannabis Subsidiaries' assets and liabilities and elimination of their equity components from the Company's consolidated financial statements as of January 21, 2021. Prior to the deconsolidation of the Canadian Cannabis Subsidiaries, they comprised an operating segment within the Other Products and Services reportable segment, which upon the Company's reevaluation of operating and reportable segments effective during the fourth quarter of the year ended March 31, 2022 is presented in the All Other category. Upon deconsolidation, the Company accounts for its investments in the Canadian Cannabis Subsidiaries using the cost method of accounting.

On January 29, 2021, the Canadian Court issued an order permitting the Canadian Cannabis Subsidiaries to initiate a sale and investment solicitation process to be conducted by the Monitor and its affiliate to solicit interest in, and opportunities for, a sale of, or investment in, all or substantially all, or one or more components, of the assets and/or the business operations of the Canadian Cannabis Subsidiaries. On January 28, 2022, a sale of the assets of Figr Norfolk for a purchase price of Cdn.$5,000 was completed. On June 28, 2021, a sale of the outstanding equity of Figr East and certain intangible assets of Figr Brands for an aggregate purchase price of Cdn.$24,750 was completed. On February 2, 2022, Figr Norfolk and Figr Brands obtained approval to make cash distributions to their creditors pursuant to a distribution protocol approved by the Canadian Court. In the three months ended June 30, 2022, the Company received $2,011 in settlement of its debt claims with respect to the Canadian Cannabis Subsidiaries and did not receive any recovery with respect to its equity interest in the Canadian Cannabis Subsidiaries. On April 21, 2022, Figr Norfolk and Figr Brands obtained approval from the Canadian Court to terminate the CCAA Proceedings and commence bankruptcy proceedings under Canada's Bankruptcy and Insolvency Act (the "BIA Proceedings") to complete certain corporate and tax-related wind-up activities. On May 13, 2022, Figr Norfolk and Figr Brands commenced the BIA Proceedings. On June 13, 2022, the CCAA Proceedings were formally terminated.

Related Party Relationship
The commencement of the CCAA Proceeding, the appointment of the Monitor, and the subsequent deconsolidation of the Canadian Cannabis Subsidiaries results in transactions with the Canadian Cannabis Subsidiaries no longer being eliminated in consolidation. As such, transactions between the Company and the Canadian Cannabis Subsidiaries, including loans under the debtor-in-possession financing facility (the "Canadian DIP Facility") from another non-U.S. subsidiary of Pyxus (the "DIP Lender") provided during the pendency of the CCAA Proceedings, which were fully repaid on July 8, 2021, are treated as related party transactions. See "Note 18. Related Party Transactions" for transactions between the Company and the Canadian Cannabis Subsidiaries.

8. Equity Method Investments
The following summarizes the Company's equity method investments as of June 30, 2022:

Investee Name Location Primary Purpose The Company's Ownership Percentage Basis Difference
Adams International Ltd. Thailand purchase and process tobacco 49  % $ (4,526)
Alliance One Industries India Private Ltd. India purchase and process tobacco 49  % (5,770)
China Brasil Tobacos Exportadora SA Brazil purchase and process tobacco 49  % 45,124 
Oryantal Tütün Paketleme Sanayi ve Ticaret A.Ş. Turkey process tobacco 50  % (416)
Purilum, LLC U.S. produce flavor formulations and consumable e-liquids 50  % 4,589 
Siam Tobacco Export Company Thailand purchase and process tobacco 49  % (6,098)

-11-


The following summarizes financial information for these equity method investments:

Operations statement: Three months ended June 30, 2022 Three months ended June 30, 2021
Sales $ 69,382  $ 31,432 
Gross profit 14,089  3,666 
Net income 8,330  (2,900)
Company's dividends received 11,522  8,848 

Balance sheet: June 30, 2022 June 30, 2021 March 31, 2022
Current assets $ 441,973  $ 290,750  $ 375,015 
Property, plant, and equipment and other assets 37,876  45,068  42,841 
Current liabilities 367,743  228,716  289,816 
Long-term obligations and other liabilities 2,249  3,400  2,999 

9. Variable Interest Entities
The Company holds variable interests in multiple entities that primarily procure or process inventory or are securitization entities. These variable interests relate to equity investments, receivables, guarantees, and securitized receivables. The following summarizes the Company's financial relationships with its unconsolidated variable interest entities:

June 30, 2022 June 30, 2021 March 31, 2022
Investments in variable interest entities $ 80,446  $ 78,903  $ 88,118 
Receivables with variable interest entities 16,825  19,671  2,211 
Guaranteed amounts to variable interest entities (not to exceed) 64,610  55,987  55,884 

10. Other Intangible Assets, Net
The following summarizes the changes in the Company's goodwill and other intangible assets, net:

Three months ended June 30, 2022
  Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Amortization Expense Ending Intangible Assets, Net
Intangibles subject to amortization:
Customer relationships 10.17 years $ 23,568  $ (1,455) $ 22,113 
Technology 5.82 years 11,471  (1,352) 10,119 
Trade names 12.17 years 10,022  (202) 9,820 
Total $ 45,061  $ (3,009) $ 42,052 

-12-


Year ended March 31, 2022
Weighted Average Remaining Useful Life Beginning Carrying Amount, Net Additions Amortization Expense Disposition of Humble Juice Impairment Ending Intangible Assets, Net
Intangibles subject to amortization:
Customer relationships 10.30 years $ 27,730  $ —  $ (2,427) $ (1,735) $ —  $ 23,568 
Technology 5.80 years 12,858  840  (2,227) —  —  11,471 
Trade names 12.42 years 10,829  —  (807) —  —  10,022 
Intangibles not subject to amortization:
Goodwill 36,853  —  —  (4,667) (32,186) — 
Total $ 88,270  $ 840  $ (5,461) $ (6,402) $ (32,186) $ 45,061 




-13-


11. Debt Arrangements
The following summarizes debt and notes payable:

June 30, June 30, March 31,
(in thousands) Interest Rate 2022 2021 2022
Senior secured credit facilities:
ABL Credit Facility 3.5  %
(1)
$ 90,000  $ —  $ 90,000 
Exit ABL Credit Facility 5.8  %
(1)
—  67,500  — 
DDTL Facility (2)
10.7  %
(1)
109,751  117,353  107,832 
Senior secured notes:
10.0% senior secured first lien notes (3)
10.0  % 271,678  268,168  270,762 
Exit Term Loan Credit Facility (4)
9.6  %
(1)
220,518  216,533  219,500 
Other long-term debt 1.9  %
(1)
611  2,925  239 
Notes payable to banks (5)
5.8  %
(1)
545,224  403,792  378,612 
Total debt $ 1,237,782  $ 1,076,271  $ 1,066,945 
Short-term (5)
$ 545,224  $ 403,792  $ 378,612 
Long-term:
Current portion of long-term debt $ 13,781  $ 2,686  $ 107,856 
Long-term debt 678,777  669,793  580,477 
$ 692,558  $ 672,479  $ 688,333 
Letters of credit $ 14,430  $ 4,804  $ 9,038 
(1) Weighted average rate for the trailing twelve months ended June 30, 2022. As the ABL Credit Facility has not been outstanding for a trailing twelve-month period, the interest rate is the weighted average rate from inception through June 30, 2022.
(2) Balance of $109,751 is net of original issue discount of $499. Total repayment will be $110,250, which includes a $5,250 exit fee payable upon repayment.
(3) Balance of $271,678 is net of original issue discount of $9,166. Total repayment will be $280,844.
(4) The aggregate balance of the Term Loan Credit Facility of $220,518 includes $5,436 of accrued paid-in-kind interest.
(5) Primarily foreign seasonal lines of credit.
ABL Credit Facility
On February 8, 2022, Pyxus Holdings, certain subsidiaries of Pyxus Holdings (together with Pyxus Holdings, the "Borrowers"), and the Company and its wholly owned subsidiary, Pyxus Parent, Inc., as parent guarantors, entered into an ABL Credit Agreement (the "ABL Credit Agreement"), dated as of February 8, 2022, by and among Pyxus Holdings, as Borrower Agent, the Borrowers and parent guarantors party thereto, the lenders party thereto, and PNC Bank, National Association, as Administrative Agent and Collateral Agent, to establish an asset-based revolving credit facility (the "ABL Credit Facility"), the proceeds of which may be used to refinance existing senior bank debt, pay fees and expenses related to the ABL Credit Facility, partially fund capital expenditures, and provide for the ongoing working capital needs of the Borrowers. The ABL Credit Facility may be used for revolving credit loans and letters of credit from time to time up to an initial maximum principal amount of $100,000, subject to the limitations described below in this paragraph. The ABL Credit Facility includes a $20,000 uncommitted accordion feature that permits Pyxus Holdings, under certain conditions, to solicit the lenders under the ABL Credit Facility to provide additional revolving loan commitments to increase the aggregate amount of the revolving loan commitments under the ABL Credit Facility not to exceed a maximum principal amount of $120,000. A detailed description of the ABL Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022. At June 30, 2022, Pyxus Holdings was in compliance with the covenants under the ABL Credit Agreement.

Exit ABL Credit Facility
On August 24, 2020, Pyxus Holdings entered into the Exit ABL Credit Agreement to establish the Exit ABL Credit Facility. The Exit ABL Credit Facility may be used for revolving credit loans and letters of credit from time to time up to an initial maximum principal amount of $75,000, subject to certain limitations. On February 8, 2022, Pyxus Holdings terminated the Exit ABL Credit Agreement and repaid $56,500 outstanding thereunder with proceeds from the initial borrowing under the ABL Credit Facility.

-14-


DDTL Facility
On April 23, 2021, Intabex Netherlands B.V. ("Intabex"), an indirect wholly owned subsidiary of the Company, entered into a Term Loan Credit Agreement (the "DDTL Facility Credit Agreement"), dated as of April 23, 2021 (the "Closing Date"), by and among (i) Intabex, as borrower, (ii) the Company, Pyxus Parent, Inc., Pyxus Holdings, Inc., Alliance One International, LLC, Alliance One International Holdings, Ltd, as guarantors (collectively, the "Parent Guarantors"), (iii) certain funds managed by Glendon Capital Management, L.P. and Monarch Alternative Capital LP, as lenders (collectively and, together with any other lender that is or becomes a party thereto as a lender, the "DDTL Facility Lenders"), and (iv) Alter Domus (US) LLC, as administrative agent and collateral agent (the "DDTL Agent"). The DDTL Facility Credit Agreement established a $120,000 delayed-draw term loan credit facility (the "DDTL Facility") under which the full amount has been drawn (the "DDTL Loans"). After that date, a fund managed by Owl Creek Asset Management, L.P. became a lender under the DDTL Facility. The proceeds of the DDTL Loans were used to provide working capital and for other general corporate purposes of Intabex, the Guarantors (as defined below) and their subsidiaries.

The obligations of Intabex under the DDTL Facility Credit Agreement (and certain related obligations) are (a) guaranteed by the Parent Guarantors and Alliance One International Tabak B.V., an indirect subsidiary of the Company, and each of the Company’s domestic and foreign subsidiaries that is or becomes a guarantor of borrowings under the Term Loan Credit Agreement (which subsidiaries are referred to collectively, together with the Parent Guarantors, as the "Guarantors"), and (b) are secured by the pledge of all of the outstanding equity interests of (i) Alliance One Brasil Exportadora de Tabacos Ltda. ("AO Brazil"), which principally operates the Company’s leaf tobacco operations in Brazil, and (ii) Alliance One International Tabak B.V., which owns a 0.001% interest of AO Brazil.

A detailed description of the DDTL Facility Credit Agreement is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022. At June 30, 2022, Intabex and each Guarantor was in compliance with the covenants under the DDTL Facility Credit Agreement.

As described below, the DDTL Facility Credit Agreement was amended and restated on July 28, 2022. The portion of the DDTL Facility that was refinanced on a long-term basis, effective July 28, 2022, is classified as noncurrent and recorded in Long-term debt within the condensed consolidated balance sheet as of June 30, 2022.

Amendment and Restatement of DDTL Facility Credit Agreement
On June 2, 2022, Intabex, the Company and the Guarantors entered into an Amendment and Restatement Agreement dated as of June 2, 2022 (the "Amendment and Restatement Agreement") with the DDTL Facility Lenders and the DDTL Agent to, subject to the satisfaction of customary closing conditions, amend and restate the DDTL Facility Credit Agreement as set forth in the form of an Amended and Restated Term Loan Credit Agreement (the "Amended Credit Agreement"), appended to the Amendment and Restatement Agreement, among (i) Intabex, as borrower, (ii) the Company and the Guarantors, (iii) the DDTL Facility Lenders and any other lender that becomes a party thereto (collectively, the "Term Loan Lenders"), and (iv) the DDTL Agent, as administrative agent and collateral agent. On July 28, 2022, following the satisfaction of the conditions to effectiveness specified in the Amendment and Restatement Agreement, the amendment and restatement of the DDTL Facility Credit Agreement by the Amended Credit Agreement became effective. See "Note 20. Subsequent Events" for additional information.

The Amended Credit Agreement establishes a $100,000 term loan credit facility (the "Term Loan Facility") and requires that Intabex use the net proceeds of the loans made thereunder (the "Term Loans") and other funds to repay in full its obligations under the DDTL Facility Credit Agreement, including the outstanding principal of, and accrued and unpaid interest on, borrowings under the DDTL Facility on the Amendment and Restatement Effectiveness Date and the payment of fees and expenses incurred in connection with repaying such borrowings and entering into the Amended Credit Agreement.

The Term Loans mature on December 2, 2023. The Amended Credit Agreement provides that the Term Loans may be prepaid at any time, with a 2.0% fee due with respect to any principal payment made after the one-year anniversary of the Amendment and Restatement Effectiveness Date, including a payment made at maturity. The Amended Credit Agreement further provides that amounts of principal that are prepaid may not be reborrowed under the Term Loan Facility. Under the Amended Credit Agreement, interest on the outstanding principal amount of the Term Loans accrues at an annual rate of SOFR plus 7.5%, subject to a SOFR floor of 1.0%, for "SOFR loans" or, for loans that are not SOFR loans, at an annual rate of an alternate base rate (as specified in the Amended Credit Agreement and subject to a specified floor) plus 6.5%. Interest is to be paid in arrears in cash upon prepayment, acceleration, maturity, and on the last day of each interest period (which may be one, three or six months) for SOFR loans and on the last day of each calendar quarter for loans that are not SOFR loans. Pursuant to the Amended Credit Agreement, the Term Loan Lenders received on the Amendment and Restatement Effectiveness Date a non-refundable commitment fee equal to 3.0% of the aggregate commitments under the Term Loan Facility and a closing fee equal to 1.0% of the aggregate commitments under the Term Loan Facility, as original issue discount.

-15-


Under the Amended Credit Agreement, the obligations of Intabex under the Amended Credit Agreement (and certain related obligations) continue to be guaranteed and secured by the same guarantors of, and the same collateral securing, Intabex’s obligations under the DDTL Facility Credit Agreement.

Related Party Transactions
Based on a Schedule 13D filed with the SEC on September 3, 2020 by Glendon Capital Management, L.P. (the "Glendon Investor"), Glendon Opportunities Fund, L.P. and Glendon Opportunities Fund II, L.P., the Glendon Investor reported beneficial ownership of 7,939 shares of the Company’s common stock, representing approximately 31.8% of the outstanding shares of the Company’s common stock. Based on Form 4 filed with the SEC on July 15, 2021, as well as a Schedule 13D filed with the SEC on September 3, 2020 by Monarch Alternative Capital LP (the "Monarch Investor"), MDRA GP LP and Monarch GP LLC, the Monarch Investor reported beneficial ownership of 6,140 shares of the Company’s common stock, representing approximately 24.6% of the outstanding shares of the Company’s common stock. Based on a Schedule 13G/A filed with the SEC on February 10, 2022 by Owl Creek Asset Management, L.P. and Jeffrey A. Altman, Owl Creek Asset Management, L.P. is the investment manager of certain funds and reported beneficial ownership of 2,405 shares of the Company’s common stock on December 31, 2021, representing approximately 9.6% of the outstanding shares of the Company’s common stock. Pursuant to the Shareholders Agreement, Holly Kim and Patrick Fallon were designated to serve as directors of Pyxus and each continues to serve as a director of Pyxus. Ms. Kim is a Partner at Glendon Capital Management, L.P. and Mr. Fallon is a Managing Principal at Monarch Alternative Capital LP.

The DDTL Facility Credit Agreement, the Amendment and Restatement Agreement, the Amended Credit Agreement and any and all borrowings under the DDTL Facility Credit Agreement and the Amended Credit Agreement and the guaranty transactions described above were approved, and determined to be on terms and conditions at least as favorable to the Company and its subsidiaries as could reasonably have been obtained in a comparable arm’s-length transaction with an unaffiliated party, by a majority of the disinterested members of the Board of Directors of Pyxus.

Senior Secured First Lien Notes
On the August 24, 2020, Pyxus Holdings issued approximately $280,844 in aggregate principal amount of the Notes to holders of Allowed First Lien Notes Claims pursuant to the Indenture dated as of August 24, 2020 (the "Indenture") among Pyxus Holdings, the initial guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent. A detailed description of the Notes and the Indenture is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022. At June 30, 2022, Pyxus Holdings was in compliance with the covenants under the Indenture.

Exit Term Loan Credit Facility
On August 24, 2020, Pyxus Holdings entered into the Exit Term Loan Credit Agreement by and among, amongst others, Pyxus Holdings, certain lenders party thereto and Alter Domus (US) LLC, as administrative agent and collateral agent to establish the Exit Term Loan Credit Facility in an aggregate principal amount of approximately $213,418. The aggregate principal amount of loans outstanding under Debtors’ debtor-in-possession financing facility, and related fees, was converted into, or otherwise satisfied with the proceeds of, the Exit Term Loan Credit Facility. A detailed description of the Exit Term Loan Credit Agreement and Exit Term Loan Credit Facility is included in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022. At June 30, 2022, Pyxus Holdings was in compliance with the covenants under the Exit Term Loan Credit Agreement.

Short-Term Seasonal Lines of Credit
Excluding all long-term credit agreements, the Company has typically financed its non-U.S. operations with uncommitted short-term seasonal lines of credit arrangements with a number of banks. These operating lines are generally seasonal in nature, typically extending for a term of 180 to 270 days corresponding to the tobacco crop cycle in that location. These facilities are typically uncommitted in that the lenders have the right to cease making loans and demand repayment of loans at any time. These loans are typically renewed at the outset of each tobacco season. Certain of the foreign seasonal lines of credit are secured by trade receivables and inventories as collateral.

African Lines of Credit
On June 30, 2022, the Company and certain subsidiaries of the Company, including the Company’s subsidiaries in Malawi, Tanzania and Zambia (the "African Subsidiary Borrowers"), entered into the Fourth Amendment and Restatement Agreement dated as of June 27, 2022 (the "Restated TDB Agreement") with Eastern and Southern African Trade and Development Bank ("TDB") to amend and restate the Third Amendment and Restatement Agreement dated August 12, 2021 among them. The Restated TDB Agreement sets forth the terms that govern the foreign seasonal lines of credit of each of the African Subsidiary Borrowers with TDB and supersedes the prior terms in effect. The Restated TDB Agreement provides for a lending commitment with respect to the line of credit of the Company’s Malawi subsidiary of $100,000, a lending commitment with respect to the line of credit of the Company’s Tanzania subsidiary of $70,000, and a lending commitment with respect to the line of credit of the Company’s Zambia subsidiary of $15,000, in each case with current borrowing availability reduced by the
-16-


amount of outstanding loans borrowed under the respective prior-existing line of credit with TDB. The prior-existing outstanding loans under the Restated TDB Agreement bear interest at LIBOR plus 6.0% and new loans made under the Restated TDB Agreement bear interest at LIBOR plus 5.5%. The Restated TDB Agreement terminates on June 30, 2024, unless terminated sooner at TDB’s discretion on June 30, 2023. The terms of the Restated TDB Agreement may also be modified at TDB’s discretion on that date. Borrowings under the Restated TDB Agreement are due upon the termination of the Restated TDB Agreement.

Pursuant to the Restated TDB Agreement, each of the Company and its subsidiaries, Pyxus Parent, Inc. and Pyxus Holdings, Inc., guarantee the obligations of the African Subsidiary Borrowers under the Restated TDB Agreement. In addition, the Restated TDB Agreement provides that obligations of each African Subsidiary Borrower under the Restated TDB Agreement are secured by a first priority pledge of:

tobacco purchased by that African Subsidiary Borrower that is financed by TDB;
intercompany receivables arising from the sale of the tobacco financed by TDB;
customer receivables arising from the sale of the tobacco financed by TDB; and
such African Subsidiary Borrower’s local collection account receiving customer payments for purchases of tobacco financed by TDB.

The Restated TDB Agreement also requires Alliance One International, LLC, a subsidiary of the Company, to pledge customer receivables arising from the sale of the tobacco financed by TDB and pledge its collection accounts designated for receiving customer payments for purchases of tobacco financed by TDB.

The Restated TDB Agreement contains affirmative and negative covenants (subject, in each case, to customary and other exceptions and qualifications), including covenants that limit the ability of the African Subsidiary Borrowers to, among other things:

Grant liens on assets;
Incur additional indebtedness (including guarantees and other contingent obligations);
Sell or otherwise dispose of property or assets;
Maintain a specified amount of pledged accounts receivable and inventory;
Make changes in the nature of its business;
Enter into burdensome contracts; and
Effect certain modifications or terminations of customer contracts.

The Restated TDB Agreement contains events of default including, but not limited to, nonpayment of principal or interest, violation of covenants, breaches of representations and warranties, cross-default to other debt, bankruptcy and other insolvency events, invalidity of loan documentation, certain changes of control of the Company and the other loan parties, termination of material licenses and material adverse changes.

At June 30, 2022, the Company and its subsidiaries party to the Restated TDB Agreement were in compliance with all such covenants under the Restated TDB Agreement and $55,642 was available for borrowing under the Restated TDB Agreement, after reducing availability by the aggregate borrowings under the Restated TDB Agreement of $129,358 outstanding on that date.

12. Securitized Receivables
The Company sells trade receivables to unaffiliated financial institutions under three accounts receivable securitization facilities, which are subject to annual renewal. Under the first facility, the Company continuously sells a designated pool of trade receivables to a special purpose entity, which sells 100% of the receivables to an unaffiliated financial institution. As of June 30, 2022, the investment limit of this facility was $100,000 of trade receivables.
For the other facilities, the Company offers trade receivables for sale to an unaffiliated financial institution, which are then subject to acceptance by the unaffiliated financial institution. As of June 30, 2022, the investment limit under the second facility was $80,000 of trade receivables. As of June 30, 2022, the investment limit under the third facility was variable based on qualifying sales.
As the servicer of the first and second facilities, the Company may receive funds that are due to the unaffiliated financial institutions, which are net settled on the next settlement date. As of June 30, 2022 and 2021, and March 31, 2022, trade
-17-


receivables, net in the condensed consolidated balance sheets has been reduced by $14,893, $4,724, and $1,872 as a result of the net settlement, respectively. Refer to "Note 15. Fair Value Measurements" for additional information.
The following summarizes the accounts receivable securitization information:

June 30, 2022 June 30, 2021 March 31, 2022
Receivables outstanding in facility $ 179,761  $ 66,671  $ 131,092 
Beneficial interests 22,762  20,271  28,072 

Three months ended June 30, 2022 Three months ended June 30, 2021
Cash proceeds for the period ended:
Cash purchase price $ 153,449  $ 90,012 
Deferred purchase price 45,468  37,681 
Total $ 198,917  $ 127,693 

13. Guarantees
In certain markets, the Company guarantees bank loans for suppliers to finance their crops. The Company also guarantees bank loans of certain unconsolidated subsidiaries. The following summarizes amounts guaranteed and the fair value of those guarantees:

June 30, 2022 June 30, 2021 March 31, 2022
Amounts guaranteed (not to exceed) $ 118,615  $ 95,272  $ 114,208 
Amounts outstanding under guarantee (1)
45,552  32,461  49,413 
Fair value of guarantees 2,601  1,962  2,956 
Amounts due to local banks on behalf of suppliers for government subsidized rural credit financing 6,376  12,216  15,781 
(1) Most of the guarantees outstanding at June 30, 2022 expire within one year.

14. Derivative Financial Instruments
The Company uses forward or option currency contracts to manage risks associated with foreign currency exchange rates on foreign operations. These contracts are for green tobacco purchases, processing costs, and selling, general, and administrative expenses. The Company recorded a net gain of $862 and $415 from its derivative financial instruments in cost of goods and services sold for the three months ended June 30, 2022 and 2021, respectively. As of June 30, 2022 and 2021, the Company recorded current derivative assets of $560 and $4,896 within other current assets, respectively. The U.S. Dollar notional amount of derivative contracts outstanding as of June 30, 2022 and 2021 was $7,259 and $53,436, respectively.

-18-


15. Fair Value Measurements
The following summarizes the financial assets and liabilities measured at fair value on a recurring basis:
    
June 30, 2022 June 30, 2021 March 31, 2022
Total Total Total
Level 2 Level 3 at Fair Value Level 2 Level 3 at Fair Value Level 2 Level 3 at Fair Value
Financial Assets:
Derivative financial instruments $ 560  $ —  $ 560  $ 4,896  $ —  $ 4,896  $ 9,867  $ —  $ 9,867 
Securitized beneficial interests —  22,762  22,762  —  20,271  20,271  —  28,072  28,072 
Total assets $ 560  $ 22,762  $ 23,322  $ 4,896  $ 20,271  $ 25,167  $ 9,867  $ 28,072  $ 37,939 
Financial Liabilities:
Long-term debt $ 430,573  $ 660  $ 431,233  $ 450,724  $ 3,164  $ 453,888  $ 447,843  $ 246  $ 448,089 
Guarantees —  2,601  2,601  —  1,962  1,962  —  2,956  2,956 
Total liabilities $ 430,573  $ 3,261  $ 433,834  $ 450,724  $ 5,126  $ 455,850  $ 447,843  $ 3,202  $ 451,045 

The following summarizes the reconciliation of changes in Level 3 instruments measured on a recurring basis:

Three months ended June 30, 2022 Three months ended June 30, 2021
Securitized Beneficial Interests Long-Term Debt Guarantees Securitized Beneficial Interests Long-Term Debt Guarantees
Beginning balance $ 28,072  $ 246  $ 2,956  $ 19,370  $ 3,162  $ 1,740 
Issuances of sales of receivables/guarantees —  —  206  —  —  223 
Settlements (33,361) —  (535) (36,695) —  (26)
Additions 29,033  414  —  38,498  — 
(Losses) gains recognized in earnings (982) —  (26) (902) —  25 
Ending balance $ 22,762  $ 660  $ 2,601  $ 20,271  $ 3,164  $ 1,962 

For the three months ended June 30, 2022 and 2021, the impact to earnings attributable to the change in unrealized losses on securitized beneficial interests was $618 and $319, respectively.

16. Pension and Other Postretirement Benefits
On November 19, 2021, the Compensation Committee of the Company's Board of Directors approved a resolution to terminate the Company's U.S. defined benefit pension plan ("U.S. Pension Plan"). Termination of the U.S. Pension Plan is a twelve-to-eighteen month process. The Company will settle benefits directly with vested participants electing a lump sum payout and purchase a group annuity contract to administer future payments to the remaining U.S. Pension Plan participants. Based on the estimated value of assets held in the U.S. Pension Plan, the Company estimates that a cash contribution of between $3,000 and $5,000 will be required to fully fund the U.S. Pension Plan's liabilities upon termination. In addition, the Company expects to record a pension settlement charge at plan termination, which includes the reclassification of unrecognized pension gains and losses within accumulated other comprehensive income (loss) to other (expense) income, net within the Company's condensed consolidated statements of operations. The Company does not have an estimate for this future settlement charge. The amount of unrecognized pension gains within accumulated other comprehensive income (loss) related to the U.S. Pension Plan is approximately $5,401 at June 30, 2022.

17. Contingencies and Other Information
Brazilian Tax Credits
The government in the Brazilian State of Parana ("Parana") issued a tax assessment on October 26, 2007 with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At June 30, 2022, the assessment for intrastate trade tax credits taken is $2,515 and the total assessment including penalties and interest is $9,386. On March 18, 2014, the government in Brazilian State of Santa Catarina also issued a tax assessment with respect to local intrastate trade tax credits that result primarily from tobacco transferred between states within Brazil. At June 30, 2022, the assessment for intrastate trade tax credits taken is $2,175 and the total assessment including penalties and interest is $6,057. The Company believes it has properly complied with Brazilian law and will contest any assessment through the judicial process. Should the
-19-


Company lose in the judicial process, the loss of the intrastate trade tax credits would have a material impact on the financial statements of the Company.

The Company also has local intrastate trade tax credits in the Brazil State of Rio Grande do Sul. This jurisdiction permits the sale or transfer of excess credits to third parties, however approval must be obtained from the tax authorities. The Company has an agreement with the state government regarding the amounts and timing of credits that can be sold. The tax credits have a carrying value of $16,708. The intrastate trade tax credits are monitored for impairment in future periods based on market conditions and the Company’s ability to use or sell the tax credits.

Other Matters
In addition to the above-mentioned matters, certain of the Company’s subsidiaries are involved in other litigation or legal matters incidental to their business activities, including tax matters. While the outcome of these matters cannot be predicted with certainty, they are being vigorously defending and the Company does not currently expect that any of them will have a material adverse effect on its business or financial position. However, should one or more of these matters be resolved in a manner adverse to its current expectation, the effect on the Company’s results of operations for a particular fiscal reporting period could be material.
Asset Retirement Obligations
The Company identified an asset retirement obligation ("ARO") associated with one of its facilities that requires it to restore the land to its initial condition upon vacating the facility. The Company has not recognized a liability under generally accepted accounting principles for this ARO as the fair value of restoring the land at this site cannot be reasonably estimated since the settlement date is unknown at this time. The settlement date is unknown because the land restoration is not required until title is returned to the government, and the Company has no current or future plans to return the title. The Company will recognize a liability in the period in which sufficient information is available to reasonably estimate its fair value.

18. Related Party Transactions
The Company engages in transactions with its equity method investees primarily for the procuring and processing of inventory. The following summarizes sales and purchases transactions with related parties:

Three months ended June 30, 2022 Three months ended June 30, 2021
Sales $ 10,622  $ 10,637 
Purchases 25,841  22,342 

The Company included the following related party balances in its condensed consolidated balances sheets:

June 30, 2022 June 30, 2021 March 31, 2022 Location in the Condensed Consolidated Balance Sheets
Accounts receivable, related parties $ 17,750  $ 4,138  $ 1,896  Other receivables
Notes receivable, related parties —  17,301  1,431  Other receivables
Accounts payable, related parties 10,403  15,124  41,747  Accounts payable
Advances from related parties 1,342  14,550  15,240  Advances from customers

Transactions with Significant Shareholders
On August 24, 2020, the Company entered into an Exit Term Loan Credit Agreement and issued Senior Secured First Lien Notes with certain lenders, including the Glendon Investor and the Monarch Investor.

On April 23, 2021, the Company and certain of its subsidiaries with certain funds managed by the Glendon Investor and the Monarch Investor, as lenders, and related matters entered into a $120,000 delayed-draw credit facility agreement (see "Note 11. Debt Arrangements" for additional information). After that date, a fund managed by Owl Creek Asset Management, L.P. became a lender under the DDTL Facility. On December 30, 2021, the Company repaid $15,375 of the DDTL facility. On June 2, 2022, Intabex, the Company and the Guarantors entered into an Amendment and Restatement Agreement with the DDTL Facility Lenders and the DDTL Agent to amend and restate the DDTL Facility Credit Agreement as set forth in Amended Credit Agreement, which became effective on July 28, 2022 (see "Note 11. Debt Arrangements" and "Note 20. Subsequent Events" for additional information).

Accrued expenses and other current liabilities as presented in the condensed consolidated balance sheets as of June 30, 2022 and 2021, and March 31, 2022, includes $5,953, $6,361, and $3,984, respectively, of interest payable to the Glendon Investor,
-20-


the Monarch Investor, and funds managed by Owl Creek Asset Management, L.P. Interest expense as presented in the condensed consolidated statements of operations includes $8,097 and $7,499 for the three months ended June 30, 2022 and 2021, respectively, that relates to the Glendon Investor, the Monarch Investor, and funds managed by Owl Creek Asset Management, L.P.

Transactions with the Deconsolidated Canadian Cannabis Subsidiaries
In connection with the CCAA Proceeding, the DIP Lender, another non-U.S. subsidiary of the Company, provided Figr Brands with secured debtor-in-possession financing to fund the working capital needs of the Canadian Cannabis Subsidiaries in accordance with the cash flow projections approved by the Monitor and the DIP Lender. These payments also funded fees and expenses paid to the DIP Lender, professional fees and expenses incurred by the Canadian Cannabis Subsidiaries and the Monitor in respect of the CCAA Proceeding, and such other costs and expenses of the Canadian Cannabis Subsidiaries as agreed to by the DIP Lender.

As of June 30, 2022 and 2021, and March 31, 2022, the outstanding loan balance under the Canadian DIP Facility was $0, $11,082, and $0, respectively, and is included in other receivables within the condensed consolidated balance sheets. On July 8, 2021, the loans under the Canadian DIP Facility were fully repaid to the DIP Lender.

19. Segment Information
The following summarizes segment information, with the All Other category being included for purposes of reconciliation of the respective balances below of the Leaf segment (the Company's sole reportable segment) to the condensed consolidated financial statements:

Three months ended June 30, 2022 Three months ended June 30, 2021
Sales and other operating revenues:
Leaf $ 340,626  $ 329,858 
All Other 3,279  3,432 
Consolidated sales and other operating revenues $ 343,905  $ 333,290 
Segment operating income:
Leaf $ 11,629  $ 14,778 
All Other (4,377) (6,341)
Segment operating income 7,252  8,437 
Restructuring and asset impairment charges 300  233 
Consolidated operating income $ 6,952  $ 8,204 

June 30, 2022 June 30, 2021 March 31, 2022
Segment assets:
Leaf $ 1,760,557  $ 1,598,242  $ 1,641,552 
All Other 51,889  83,586  56,975 
Total assets $ 1,812,446  $ 1,681,828  $ 1,698,527 

20. Subsequent Events

On July 28, 2022, the Amended Credit Agreement became effective (see "Note 11. Debt Arrangements" for additional information). In connection with the effectiveness of the Amended Credit Agreement, the Glendon Investor, the Monarch Investor, and a fund managed by Owl Creek Asset Management, L.P. received $5,119 of the aggregate $5,250 in exit fee payments from the repayment of the principal amount under the DDTL Facility. The Glendon Investor, the Monarch Investor and a fund managed by Owl Creek Asset Management, L.P. received in the aggregate $3,900 of the total $4,000 in commitment and closing fees, which were reflected as original issue discount, paid to all Term Loan Lenders in connection with the aggregate $97,500 principal amount of the Term Loans made by them of the total $100,000 aggregate principal amount of the Term Loans made by all Term Loan Lenders.
-21-



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements
Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in this Quarterly Report on Form 10-Q, in our Annual Report on Form 10-K for the year ended March 31, 2022 and in our other filings with the Securities and Exchange Commission. These risks and uncertainties include:

risks related to the Company's indebtedness, including that the Company has substantial debt which may adversely affect it by limiting future sources of financing, interfering with its ability to pay interest, and principal on its indebtedness and subjecting it to additional risks, the Company requires a significant amount of cash to service indebtedness and its ability to generate cash depends on many factors beyond its control, the Company may not be able to refinance or renew its indebtedness, which may have a material adverse effect on its financial condition, the Company may not be able to satisfy the covenants included in its financing arrangements, which could result in the default of its outstanding debt obligations, and despite current indebtedness levels, the Company may still be able to incur substantially more debt, which could exacerbate further the risks associated with its significant leverage;

risks and uncertainties relating to the Company's liquidity, including but not limited to: whether foreign lenders that have provided short-term operating credit lines to fund leaf tobacco operations at the local level cease to provide such funding, uncertainty and continuing risks associated with the Company’s ability to achieve its goals and continue as a going concern, and unanticipated developments with respect to liquidity needs and sources of liquidity could result in a deficiency in liquidity;

risk and uncertainties related to the Company’s leaf tobacco operations, including changes in the timing of anticipated shipments, changes in anticipated geographic product sourcing, changes in relevant capital markets affecting the terms and availability of short-term seasonal financing, political instability, currency and interest rate fluctuations, the impact of high inflation, shifts in the global supply and demand position for tobacco products, changes in tax laws and regulations or the interpretation of tax laws and regulations, resolution of tax matters, adverse weather conditions, the impact of climate change on weather patterns in tobacco-growing regions, the impact of disasters or other unusual events affecting international commerce, the impacts of potential international sanctions on the Company's ability to sell or source tobacco in certain regions, potential changes in governmental regulations applicable to tobacco products, and changes in costs incurred in supplying products and related services; and

risks and uncertainties related to the COVID-19 pandemic, including possible delays in shipments of leaf tobacco, including from the closure or restricted activities at ports or other channels, disruptions to the Company’s operations or the operations of suppliers and customers resulting from restrictions on the ability of employees and others in the supply chain to travel and work, border closures, determinations by Pyxus or shippers to temporarily suspend operations in affected areas, whether the Company’s operations that have been classified as "essential" under various governmental orders restricting business activities will continue to be so classified or, even if so classified, whether site-specific health and safety concerns related to COVID-19 might otherwise require operations at any of the Company's facilities to be halted for some period of time, negative consumer purchasing behavior with respect to the Company’s products or the products of its leaf tobacco customers during periods of government mandates restricting activities imposed in response to the COVID-19 pandemic, and the extent to which the impact of the COVID-19 pandemic on the Company’s operations and the demand for its products may not coincide with impacts experienced in the United States due to the international scope of its operations, including in emerging and other markets in which the Company operates where the timing and severity of COVID-19 outbreaks and the pace of COVID-19 vaccinations may differ from those in the United States.

We do not undertake to update any forward-looking statements that we may make from time to time.

-22-


Executive Summary
We have experienced strong demand thus far in fiscal 2023. As expected, our first quarter was consistent with the prior fiscal year, with increased demand and more normalized timing of shipments from Asia, partially offset by the timing of shipments from Africa and South America. As of June 30, 2022, our inventory increased $126.0 million compared to the prior year primarily due to higher new crop green tobacco prices and processing costs in South America, and accelerated new crop buying activities in certain key markets. In addition, our processed tobacco inventory continues to be more than 90% committed to specific customers. The overall increase in inventory and our committed inventory levels for processed tobacco position us to meet near-term demand and we expect to see stronger shipments in subsequent quarters in fiscal 2023, consistent with historical trends. Despite higher green tobacco prices and processing costs in South America, we were able to effectively manage our working capital to meet our purchasing goals for the current crop cycle.

Crop sizes in certain markets in Africa, Asia, and South America are below expectations due to the adverse impacts of prevailing La Nina weather patterns during the growing season, which has exacerbated supply shortages. We continue to engage with customers in transparent dialogue regarding the impact of inflation and La Nina on our business. In response to these and other market dynamics, we accelerated buying activities in certain key markets, and continued to invest in research trials, local programs, and additional training for our global agronomy team to further support our efforts to maximize grower efficiencies and yield despite unpredictable weather patterns. Moving forward, we are committed to recovering crop sizes, and aligning volumes in future years with customer expectations, as we work to deliver stakeholder value, and together, grow a better world.
Overview
Historically, Pyxus’ core business has been as a tobacco leaf merchant, purchasing, processing, packing, storing and shipping tobacco to manufacturers of cigarettes and other consumer tobacco products throughout the world. Through our predecessor companies, we have a long operating history in the leaf tobacco industry with some customer relationships beginning in the early 1900s.

We are committed to responsible crop production that supports economic viability for the supplier, provides a safe working atmosphere for those involved in crop production and minimizes negative environmental impact. Our agronomists maintain frequent contact with suppliers prior to and during the growing and curing seasons to provide technical assistance to improve the quality and yield of the crop. Throughout the entire production process, from seed through processing and final shipment, our SENTRI® traceability system provides clear visibility into how products are produced throughout the supply chain, supporting product integrity.

We also provide agronomy expertise for growing leaf tobacco in numerous markets. Our contracted tobacco grower base produces a significant volume of non-tobacco crop utilizing the agronomic assistance that our team provides. Pyxus works with our grower base, as needed, to find markets for these crops as part of our ongoing efforts to improve farmer livelihoods and the communities in which they live.

Historically, the Company had nine operating segments that were organized by product category and geographic area and were aggregated into three reportable segments for financial reporting purposes: Leaf - North America, Leaf - Other Regions, and Other Products and Services. During year ended March 31, 2022, the Company reevaluated its operating and reportable segments under ASC Topic 280 - Segment Reporting. As a result of this reevaluation, effective during the fourth quarter of the year ended March 31, 2022, the Company has eight operating segments organized by geographic area and product category and are aggregated into one reportable segment for financial reporting purposes: Leaf. An All Other category is included for purposes of reconciliation of the results of the Leaf reportable segment to the consolidated results. See "Note 1. Basis of Presentation and Summary of Significant Accounting Policies" for additional information.


-23-



Results of Operations
Three Months Ended June 30, 2022 and 2021
Change
(in millions, except per kilo amounts) Three months ended June 30, 2022 Three months ended June 30, 2021 $ %
Sales and other operating revenues $ 343.9  $ 333.3  10.6  3.2 
Cost of goods and services sold 303.2  291.2  12.0  4.1 
Gross profit* 40.8  42.1  (1.3) (3.1)
Selling, general, and administrative expenses 34.6  33.8  0.8  2.4 
Other income, net 1.1  0.2  0.9  450.0 
Restructuring and asset impairment charges 0.3  0.2  0.1  50.0 
Operating income* 7.0  8.2  (1.2) (14.6)
Loss on deconsolidation/disposition of subsidiaries 0.6  —  0.6  100.0 
Interest expense, net 25.5  26.8  (1.3) (4.9)
Income tax benefit 0.9  8.4  (7.5) (89.3)
Income (loss) from unconsolidated affiliates 3.7  (1.4) 5.1  364.3 
Net income (loss) attributable to noncontrolling interests 0.2  (0.1) 0.3  300.0 
Net loss attributable to Pyxus International, Inc. $ (14.7) $ (11.5) (3.2) (27.8)
Leaf:
Sales and other operating revenues $ 322.9  $ 311.7  11.1  3.6 
Tobacco costs 266.0  251.8  14.2  5.6 
Transportation, storage, and other period costs 20.6  21.5  (0.9) (4.1)
Total cost of goods sold 286.6  273.3  13.3  4.9 
Product revenue gross profit 36.3  38.5  (2.2) (5.7)
Product revenue gross profit as a percent of sales 11.2  % 12.3  %
Kilos sold 72.1  69.1  3.0  4.3 
Average price per kilo $ 4.48  $ 4.51  (0.03) (0.7)
Average cost per kilo 3.98  3.96  0.02  0.5 
Average gross profit per kilo 0.50  0.55  (0.05) (9.1)
Processing and other revenues $ 17.7  $ 18.1  (0.4) (2.1)
Processing and other revenues costs of services sold 12.5  12.4  0.2  1.2 
Processing and other gross profit 5.2  5.7  (0.5) (9.2)
Processing and other gross profit as a percent of sales 29.3  % 31.6  %
All Other:
Sales and other operating revenues $ 3.3  $ 3.4  (0.2) (4.5)
Cost of goods and services sold 4.0  5.5  (1.5) (27.5)
Gross loss (0.7) (2.1) 1.4  65.7 
Gross loss as a percent of sales (21.6) % (60.2) %
* Amounts may not equal column totals due to rounding



-24-


Sales and other operating revenues increased $10.6 million, or 3.2%, to $343.9 million for the three months ended June 30, 2022 from $333.3 million for the three months ended June 30, 2021. This increase was primarily due to a 4.3% increase in leaf volume driven by greater demand and more normalized timing of shipments from Asia. This increase was partially offset by the timing of shipments from Africa and South America.
Cost of goods and services sold increased $12.0 million, or 4.1%, to $303.2 million for the three months ended June 30, 2022 from $291.2 million for the three months ended June 30, 2021. This increase was mainly due to the increase in sales and other operating revenues.
Gross profit decreased $1.3 million, or 3.1%, to $40.8 million for the three months ended June 30, 2022 from $42.1 million for the three months ended June 30, 2021. Gross profit as a percent of sales decreased to 11.9% for the three months ended June 30, 2022 from 12.6% for the three months ended June 30, 2021. These decreases were driven by delayed shipments from Africa and South America and were partially offset by accelerated shipments from Asia.
Income tax benefit decreased $7.5 million, or 89.3%, to $0.9 million for the three months ended June 30, 2022 from $8.4 million for the three months ended June 30, 2021. The decrease was driven by the Company utilizing a different method for estimating tax expense (benefit) for the period ended June 30, 2022. Using the discrete method for the period ended June 30, 2022, the Company determined current and deferred income tax expense (benefit) as if the interim three-month period was a year-end period, which resulted in the recognition of the fiscal 2023 year-to-date benefit in the quarter. Refer to See "Note 4. Income Taxes" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

-25-


Liquidity and Capital Resources

Overview
Our primary sources of liquidity are cash generated from operations, cash collections from our securitized receivables, and short-term borrowings under our foreign seasonal lines of credit. Our liquidity requirements are affected by various factors from our core tobacco leaf business, including crop seasonality, foreign currency and interest rates, green tobacco prices, customer mix, crop size, and quality. Our leaf tobacco business is seasonal, and purchasing, processing, and selling activities have several associated peaks where cash on-hand and outstanding indebtedness may vary significantly compared to year end. The first three quarters generally represent the peak of our working capital requirements. Although we believe that our sources of liquidity will be sufficient to fund our anticipated operating needs for the next twelve months, we anticipate periods during which our liquidity needs for operations will approach the levels of our anticipated available cash and permitted borrowings under our credit facilities. Unanticipated developments affecting our liquidity needs, including with respect to the foregoing factors, and sources of liquidity, including impacts affecting our cash flows from operations and the availability of capital resources (including an inability to renew or refinance seasonal lines of credit), may result in a deficiency in liquidity. To address a potential liquidity deficiency, we may undertake plans to minimize cash outflows, which could include exiting operations that do not generate positive cash flow. It is possible that, depending on the occurrence of events affecting our liquidity needs and sources of liquidity, such plans may not be sufficient to adequately or timely address a liquidity deficiency.

Debt Financing
We continue to finance our business with a combination of short-term and long-term credit lines, the long-term debt securities, advances from customers, and cash from operations when available. See "Note 11. Debt Arrangements" to the "Notes to Condensed Consolidated Financial Statements" for summary of our short-term and long-term debt.

We continuously monitor and, as available, adjust funding sources as needed to enhance and drive various business opportunities. From time to time we may take steps to reduce our debt or otherwise improve our financial position. Such actions could include prepayments, open market debt repurchases, negotiated repurchases, other redemptions or retirements of outstanding debt, and refinancing of debt. The amount of prepayments or the amount of debt that may be repurchased, refinanced, or otherwise retired, if any, will depend on market conditions, trading levels of our debt, our cash position, compliance with debt covenants, and other considerations.

The following summaries our maximum borrowing amount under our short-term and long-term credit lines and letter of credit facilities and the remaining available amount after the reduction for outstanding borrowings and amounts reserved for outstanding letters of credit:

June 30, 2022
(in millions) Maximum Borrowing Amount Remaining Amount Available
ABL Credit Facility $ 100.0  $ 10.0 
Foreign seasonal lines of credit 717.2  171.9 
Other long-term debt 0.6  — 
Letters of credit 18.3  3.9 
Total $ 836.1  $ 185.8 















-26-



Net Debt
We refer to "Net debt", a non-GAAP measure, as total debt liabilities less cash and cash equivalents. We believe this non-GAAP financial measure is useful to monitor leverage and to evaluate changes to the Company's capital structure. A limitation associated with using net debt is that it subtracts cash and cash equivalents, and therefore, may imply that management intends to use cash and cash equivalents to reduce outstanding debt and that cash held in certain jurisdictions can be applied to repay obligations owing in other jurisdictions and without reduction for applicable taxes. In addition, net debt suggests that our debt obligations are less than the most comparable GAAP measure indicates.

(in millions) June 30, 2022 June 30, 2021 March 31, 2022
Notes payable to banks(1)
$ 545.2  $ 403.8  $ 378.6 
Current portion of long-term debt(2)
13.8  2.7  107.9 
Long-term debt(3)
678.8  669.8  580.5 
Total debt liabilities $ 1,237.8  $ 1,076.3  $ 1,066.9 
Less: Cash and cash equivalents 165.4  79.6  198.8 
Net debt $ 1,072.3  $ 996.7  $ 868.2 
(1) The increase from June 30, 2021 to June 30, 2022 is due to higher borrowings under the Company's foreign seasonal lines of credit in Africa and South America driven by higher prices for green tobacco purchases. The increase from March 31, 2022 to June 30, 2022 is due to seasonality of the business, with higher working capital requirements in the first quarter of the fiscal year.
(2) The decrease from March 31, 2022 is due to reclassifying the portion of the outstanding amount under the DDTL Facility from current to noncurrent as of June 30, 2022 to the extent borrowings thereunder were refinanced under the Amendment and Restatement of the DDTL Facility Credit Agreement, which became effective prior to issuance of the Company's condensed consolidated financial statements for the three months ended June 30, 2022.
(3) The increase from March 31, 2022 is due to the reclassification of a portion of the outstanding amount under the DDTL Facility from current portion of long-term debt to long-term debt as of June 30, 2022 for the reason described above. The increase in long-term debt from June 30, 2021 is due to borrowings under the new ABL Credit Facility implemented in February 2022, which increased the maximum borrowing capacity from the Exit ABL Credit Facility that it refinanced.

Working Capital

The following summarizes our working capital:
(in millions except for current ratio) June 30, 2022 June 30, 2021 March 31, 2022
Cash, cash equivalents, and restricted cash $ 174.9  $ 82.1  $ 200.9 
Trade and other receivables, net 182.8  232.0  260.2 
Inventories and advances to tobacco suppliers 1,024.1  890.7  798.4 
Recoverable income taxes 8.7  10.9  7.9 
Prepaid expenses and other current assets 61.2  54.9  60.3 
Total current assets* $ 1,451.8  $ 1,270.7  $ 1,327.6 
Notes payable to banks $ 545.2  $ 403.8  $ 378.6 
Accounts payable 144.9  88.8  179.0 
Advances from customers 46.1  29.6  53.0 
Accrued expenses and other current liabilities 91.1  91.4  82.2 
Income taxes payable 6.7  4.1  5.6 
Operating leases payable 8.5  9.0  8.1 
Current portion of long-term debt 13.8  2.7  107.9 
Total current liabilities $ 856.3  $ 629.4  $ 814.4 
Current ratio 1.7 to 1 2.0 to 1 1.6 to 1
Working capital $ 595.5  $ 641.3  $ 513.2 
* Amounts may not equal column totals due to rounding

Working capital decreased from June 30, 2021 to June 30, 2022 by $45.8 million, or 7.1%, primarily due to delayed shipments from Africa and South America, increased foreign seasonal lines of credit mainly driven by higher green tobacco prices and processing costs in South America, and increased foreign seasonal lines of credit in Africa mainly driven by higher capacity and more efficient utilization.

-27-


Inventories
The following summarizes inventory committed to a customer and uncommitted inventory balances for processed tobacco:

(in millions) June 30, 2022 June 30, 2021 March 31, 2022
Committed $ 617.6  $ 514.8  $ 471.9 
Uncommitted 28.9  70.0  45.7 
Total processed tobacco $ 646.5  $ 584.8  $ 517.6 

Total processed tobacco increased from June 30, 2021 to June 30, 2022 by $61.7 million, or 10.6%, primarily due to higher green tobacco prices and processing costs in South America, and accelerated buying activities in certain key markets. This increase was partially offset by the restructuring of certain African operations in the prior year where the Company no longer operates. See "Note 1. Basis of Presentation and Summary of Significant Accounting Policies" and "Note 6. Inventories" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

Sources and Uses of Cash
We typically finance our non-U.S. tobacco operations with uncommitted short-term foreign seasonal lines of credit. These foreign lines of credit are generally seasonal in nature, normally extending for a term of 180 to 270 days, corresponding to the tobacco crop cycle in that market. These short-term foreign seasonal lines of credit are typically uncommitted and provide lenders the right to cease making loans and demand repayment of loans. These short-term foreign seasonal lines of credit are generally renewed at the outset of each tobacco season. We maintain various other financing arrangements to meet the cash requirements of our businesses. See "Note 11. Debt Arrangements" to the "Notes to Condensed Consolidated Financial Statements" for additional information.

We utilize capital in excess of cash flow from operations to finance accounts receivable, inventory, and advances to tobacco suppliers in foreign countries. In addition, we may periodically elect to purchase, redeem, repay, retire, or cancel indebtedness prior to stated maturity under our various foreign credit lines.

As of June 30, 2022, our cash and cash equivalents was $165.4 million of which approximately $55.3 million was held in foreign jurisdictions, certain of which are subject to exchange controls and tax consequences that could limit our ability to fully repatriate these funds. Fluctuation of the U.S. dollar versus many of the currencies in which we have costs may have an impact on our working capital requirements. We will continue to monitor and hedge foreign currency costs, as needed.

The following summarizes the sources and uses of our cash flows:

(in millions) Three months ended June 30, 2022 Three months ended June 30, 2021
Operating activities $ (242.5) $ (186.0)
Investing activities 47.0  29.7 
Financing activities 168.8  140.6 
Effect of exchange rate changes on cash 0.3  0.5 
Decrease in cash, cash equivalents, and restricted cash $ (26.4) $ (15.2)

Cash, cash equivalents, and restricted cash decreased by $11.2 million more during the three months ended June 30, 2022 compared to the decrease during the three months ended June 30, 2021. This decrease was primarily due to cash used by operating activities driven by delayed shipments from Africa and South America. This decrease was partially offset by cash provided by financing activities from higher foreign seasonal lines of credit mainly driven by higher green tobacco prices and processing costs in South America, increased foreign seasonal lines of credit in Africa mainly driven by higher capacity and more efficient utilization, and cash provided by investing activities from higher collections from securitized trade receivables.

Planned Capital Expenditures
Capital investments in our leaf operations have been made primarily for routine replacement of machinery and equipment, as well as investments in assets that will add value for our customers and increase our efficiency. We have incurred approximately $2.2 million in capital expenditures for the three months ended June 30, 2022, and are expecting to incur an additional $20.0 million for the remainder of the fiscal year ending March 31, 2023.

-28-


Pension and Postretirement Health and Life Insurance Benefits
The following summarizes cash contributions to pension and postretirement health and life insurance benefits:

(in millions) Three months ended June 30, 2022
Contributions made during the period $ 1.4 
Contributions expected for the remainder of the fiscal year 3.2 
Total $ 4.6 

No cash dividends were paid to shareholders during the three months ended June 30, 2022. The payment of dividends is restricted under the terms the ABL Credit Agreement, the Term Loan Credit Agreement, and the Indenture.

Critical Accounting Policies and Estimates
As of the date of this report, there are no material changes to the critical accounting policies and estimates previously disclosed in Part I, Item 7 "Critical Accounting Policies and Estimates" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes to our market risk exposures since March 31, 2022. For a discussion of our exposure to market risk, see Part II, Item 7A "Quantitative and Qualitative Disclosures About Market Risk" contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) designed to provide reasonable assurance that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that this information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. Due to inherent limitations, our disclosure controls and procedures, however well designed and operated, can provide only reasonable assurance (not absolute) that the objectives of the disclosure controls and procedures are met.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as required by Rule 13a-15(b) of the Exchange Act), as of June 30, 2022. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) were effective to provide reasonable assurance as of June 30, 2022.

Changes in Internal Control over Financial Reporting
As required by Rule 13a-15(d) under the Exchange Act, our management, including our Chief Executive Officer and Chief Financial Officer, have evaluated our internal control over financial reporting to determine whether any changes occurred during the quarter covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There were no changes that occurred during the three months ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings

See "Note 17. Contingencies and Other Information" to the "Notes to Condensed Consolidated Financial Statements" for additional information with respect to legal proceedings, which are incorporated by reference herein.

Item 1A. Risk Factors

-29-


In addition to the other information set forth in this report and in our other filings with the Securities and Exchange Commission, investors should carefully consider our risk factors, which could materially affect our business, financial condition, or operating results. Except as set forth below, as of the date of this report, there are no material changes or updates to the risk factors previously disclosed in Part I, Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2022.

The impact of potential regulations to prohibit the sale of cigarettes in the United States other than low-nicotine cigarettes, if they are adopted and become effective, is uncertain, but they could materially adversely affect our business, results of operations and financial condition.
In June 2022, the U.S. Food and Drug Administration (the "FDA") announced its plan to publish a proposed rule in 2023 that would prohibit the sale of cigarettes in the United States other than cigarettes having significantly reduced levels of nicotine. The definitive provisions of such a proposed rule have not yet been announced and any rule proposal is subject to public comment prior to being adopted by the FDA. Accordingly, the terms of any such final rule are uncertain and the date of effectiveness of such a rule is also uncertain. While the FDA announced that reducing the nicotine levels of cigarettes would reduce consumption of cigarettes by future generations and facilitate current smokers to stop consuming cigarettes, it is uncertain whether such potential regulations, if they are adopted and become effective, will have such effect. While the impact of such potential regulations on the Company is also uncertain, such regulations, if they are adopted and become effective, could materially adversely affect our business, results of operations and financial condition.

Item 6. Exhibits

Amendment and Restatement Agreement dated as of June 2, 2022 among Intabex Netherlands B.V., Pyxus International, Inc., Pyxus Parent, Inc., Pyxus Holdings, Inc., Alliance One International, LLC, Alliance One International Holdings, Ltd, Alliance One International Tabak B.V., the other guarantors party thereto, the Lenders party thereto, and Alter Domus (US) LLC, as administrative agent and collateral agent, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Pyxus International, Inc., filed on June 7, 2022 (File No. 000-25734)
Fourth Amendment and Restatement Agreement dated 27 June 2022 among Pyxus International, Inc., Pyxus Parent, Inc., Pyxus Holdings, Inc., Alliance One Tobacco (Malawi) Limited, Alliance One Tobacco (Tanzania) Limited, Alliance One Zambia Limited and Eastern and Southern African Trade and Development Bank, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Pyxus International, Inc., filed on July 6, 2022 (File No. 000-25734)
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
101.INS
XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH
Inline XBRL Taxonomy Extension Schema (filed herewith)
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase (filed herewith)
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase (filed herewith)
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase (filed herewith)
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase (filed herewith)
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Interactive Data Files submitted as Exhibits 101.*)

-30-


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Pyxus International, Inc.
Date: August 11, 2022
/s/ Philip C. Garofolo
Philip C. Garofolo
Vice President - Chief Accounting Officer
(Principal Accounting Officer)
                
-31-
Pyxus (NYSE:PYX)
Historical Stock Chart
Von Jan 2023 bis Feb 2023 Click Here for more Pyxus Charts.
Pyxus (NYSE:PYX)
Historical Stock Chart
Von Feb 2022 bis Feb 2023 Click Here for more Pyxus Charts.